Timothy E. Morris's most recent trade in Aquestive Therapeutics Inc was a trade of 50,500 Stock Option (right to purchase) done . Disclosure was reported to the exchange on June 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics Inc | Mr. Timothy E. Morris | Director | 10 Jun 2026 | 50,500 | 50,500 | - | - | Stock Option (right to purchase) | ||
| Aquestive Therapeutics Inc | Mr. Timothy E. Morris | Director | 11 Jun 2025 | 42,000 | 42,000 | - | - | Stock Option (right to purchase) | ||
| Aquestive Therapeutics Inc | Mr. Timothy E. Morris | Director | 20 Jun 2024 | 38,000 | 38,000 | - | - | Stock Option (right to purchase) | ||
| DBV Tech (ADR) | Mr. Timothy E. Morris | Director | Purchase of securities on an exchange or from another person at price $ 1.52 per share. | 25 Aug 2023 | 12,000 | 12,000 (0%) | 0% | 1.5 | 18,240 | - |
| DBV Tech (ADR) | Mr. Timothy E. Morris | Director | Purchase of securities on an exchange or from another person at price $ 1.52 per share. | 25 Aug 2023 | 12,000 | 12,000 (0%) | 0% | 1.5 | 18,240 | - |
| Aquestive Therapeutics Inc | Mr. Timothy E. Morris | Director | 21 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to purchase) | ||
| Aquestive Therapeutics Inc | Mr. Timothy E. Morris | Director | 16 Aug 2022 | 28,500 | 28,500 | - | - | Non-Qualified Stock Option (right to buy) |